BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20131955)

  • 1. Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways.
    Li W; Liu M; Lai S; Xu C; Lu F; Xiao X; Bao Y
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):576-84. PubMed ID: 20131955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the immunomodulation of polysaccharopeptide through the TLR4-TIRAP/MAL-MyD88 signaling pathway in PBMCs from breast cancer patients.
    Wang J; Dong B; Tan Y; Yu S; Bao YX
    Immunopharmacol Immunotoxicol; 2013 Aug; 35(4):497-504. PubMed ID: 23802631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on immunomodulatory mechanism of Polysaccharopeptide mediated by TLR4 signaling pathway.
    Wang Z; Dong B; Feng Z; Yu S; Bao Y
    BMC Immunol; 2015 Jun; 16():34. PubMed ID: 26032186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immunomodulatory activity of interferon alpha on toll-like receptor 9 signaling pathway in chronic hepatitis B.
    Wang X; Zhao YR; Liu HL; Ma XH; Zhang Y
    J Interferon Cytokine Res; 2015 May; 35(5):385-91. PubMed ID: 25535670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharopeptide exerts immunoregulatory effects via MyD88-dependent signaling pathway.
    Feng Z; Wang Z; Yang M; Zhou L; Bao Y
    Int J Biol Macromol; 2016 Jan; 82():201-7. PubMed ID: 26546866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR-4 signalling pathway: MyD88 independent pathway up-regulation in chicken breeds upon LPS treatment.
    Karnati HK; Pasupuleti SR; Kandi R; Undi RB; Sahu I; Kannaki TR; Subbiah M; Gutti RK
    Vet Res Commun; 2015 Mar; 39(1):73-8. PubMed ID: 25417198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
    Schmitz F; Mages J; Heit A; Lang R; Wagner H
    Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells.
    Mendes ME; Baggio-Zappia GL; Brunialti MK; Fernandes Mda L; Rapozo MM; Salomao R
    Immunobiology; 2011 Mar; 216(3):285-95. PubMed ID: 20828866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma.
    Starska K; Forma E; Bryś M; Głowacka E; Lewy-Trenda I; Lukomski M; Krajewska WM
    Adv Med Sci; 2012 Jun; 57(1):124-35. PubMed ID: 22240197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts.
    Arranz A; Gutiérrez-Cañas I; Carrión M; Juarranz Y; Pablos JL; Martínez C; Gomariz RP
    Mol Immunol; 2008 Jun; 45(11):3065-73. PubMed ID: 18452992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two adaptor molecules of MyD88 and TRAF6 in Apostichopus japonicus Toll signaling cascade: molecular cloning and expression analysis.
    Lu Y; Li C; Zhang P; Shao Y; Su X; Li Y; Li T
    Dev Comp Immunol; 2013 Dec; 41(4):498-504. PubMed ID: 23886491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
    Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
    Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
    Hawn TR; Ozinsky A; Williams LM; Rodrigues S; Clark A; Pham U; Hill HR; Ochs H; Aderem A; Liles WC
    Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductive expression of toll-like receptor 5 (TLR5) and associated downstream signaling molecules following ligand exposure and bacterial infection in the Indian major carp, mrigal (Cirrhinus mrigala).
    Basu M; Swain B; Maiti NK; Routray P; Samanta M
    Fish Shellfish Immunol; 2012 Jan; 32(1):121-31. PubMed ID: 22085689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.